Medgend Icon

Ledgend of Medicine







discontinued


Moxifloxacin Hydrochloride FDA Approved Drugs

AVELOX [Moxifloxacin HydrochlorideC21H24FN3O4ClH]
RX
-
eq 400mg base (oral tablet)
Bayer HlthcareDec 10, 1999
  • Method of combating bacteria in a patient.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

AVELOX IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER [Moxifloxacin HydrochlorideC21H24FN3O4ClH]
RX
-
400mg/250ml (1.6mg/ml) (iv (infusion) solution)
Bayer HlthcareNov 30, 2001
  • Method of combating bacteria in a patient.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

MOXEZA [Moxifloxacin HydrochlorideC21H24FN3O4ClH]
RX
-
eq 0.5% base (ophthalmic solution/drops)
Novartis Pharms CorpNov 19, 2010
  • Method of combating bacteria in a patient.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

MOXIFLOXACIN HYDROCHLORIDE [Moxifloxacin HydrochlorideC21H24FN3O4ClH]
RX
-
eq 0.5% base (ophthalmic solution/drops)
eq 400mg base (oral tablet)
eq 400mg base/250ml (eq 1.6mg base/ml) (iv (infusion) solution)
Apotex IncJun 30, 2017
Lupin LtdMay 28, 2015
Watson Labs IncMar 6, 2015
Aurobindo Pharma LtdMar 4, 2014
Crossmedika SaJan 14, 2016
Dr Reddys Labs LtdMar 4, 2014
Mylan Pharms IncAug 31, 2015
Novel Labs IncFeb 13, 2017
Teva Pharms UsaFeb 18, 2014
Torrent Pharms LtdApr 3, 2014
Fresenius Kabi UsaApr 3, 2015
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

MOXIFLOXACIN HYDROCHLORIDE IN SODIUM CHLORIDE 0.8% IN PLASTIC CONTAINER [Moxifloxacin HydrochlorideC21H24FN3O4ClH]
RX
-
400mg/250ml (1.6mg/ml) (iv (infusion) solution)
Mylan Labs LtdMay 5, 2017
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

VIGAMOX [Moxifloxacin HydrochlorideC21H24FN3O4ClH]
RX
-
eq 0.5% base (ophthalmic solution/drops)
Novartis Pharms CorpApr 15, 2003
  • Method of combating bacteria in a patient.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.